BSEM
Price:
$3.334
Market Cap:
$56.62M
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It offers Vendaje, a structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje AC, a thicker structural tissue allograft used as a protective covering for soft tissue wounds; Vendaje OPTIC, a structural tissue allograft used as a protective covering during the repair of ocular surfaces; American Amnion AC, a human connective tissue matrix for homologous use; and American Amnion, a human connective tissue matrix for homologous use. The company was formerly known as Ca...[Read more]
Industry
Biotechnology
IPO Date
2015-03-17
Stock Exchange
OTC
Ticker
BSEM
According to BioStem Technologies, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.14. This represents a change of -59.24% compared to the average of 2.80 of the last 4 quarters.
The mean historical Current Ratio of BioStem Technologies, Inc. over the last ten years is 0.84. The current 1.14 Current Ratio has changed 13.53% with respect to the historical average. Over the past ten years (40 quarters), BSEM's Current Ratio was at its highest in in the September 2025 quarter at 4.31. The Current Ratio was at its lowest in in the March 2019 quarter at 0.
Average
0.84
Median
0.30
Minimum
0.13
Maximum
4.12
Discovering the peaks and valleys of BioStem Technologies, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 243.35%
Maximum Annual Current Ratio = 4.12
Minimum Annual Increase = -81.86%
Minimum Annual Current Ratio = 0.13
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 4.12 | 205.28% |
| 2024 | 1.35 | 67.23% |
| 2023 | 0.81 | 243.35% |
| 2022 | 0.23 | 63.71% |
| 2021 | 0.14 | 14.61% |
| 2020 | 0.13 | -30.86% |
| 2019 | 0.18 | -51.69% |
| 2018 | 0.37 | 133.81% |
| 2017 | 0.16 | -81.86% |
| 2016 | 0.88 | -10.79% |
The current Current Ratio of BioStem Technologies, Inc. (BSEM) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
2.09
5-year avg
1.33
10-year avg
0.84
BioStem Technologies, Inc.’s Current Ratio is less than IXICO plc (2.83), less than Nicox S.A. (4.18), less than Alterity Therapeutics Limited (21.98), less than Satellos Bioscience Inc. (11.13), less than Clara Technologies Corp. (3.13), less than Actinogen Medical Limited (4.19), greater than MedX Health Corp (0.04), less than Imugene Limited (1.78), greater than ZIVO Bioscience, Inc. (0.07), greater than Vicapsys Life Sciences, Inc. (0.04),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.83 | $6.51M | |
| 4.18 | $29.17M | |
| 21.98 | $76.13M | |
| 11.13 | $96.62M | |
| 3.13 | $3.60M | |
| 4.19 | $2.97M | |
| 0.04 | $8.20M | |
| 1.78 | $27.04M | |
| 0.07 | $15.55M | |
| 0.04 | $46.94M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioStem Technologies, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioStem Technologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is BioStem Technologies, Inc.'s Current Ratio?
How is the Current Ratio calculated for BioStem Technologies, Inc. (BSEM)?
What is the highest Current Ratio for BioStem Technologies, Inc. (BSEM)?
What is the 3-year average Current Ratio for BioStem Technologies, Inc. (BSEM)?
What is the 5-year average Current Ratio for BioStem Technologies, Inc. (BSEM)?
How does the current Current Ratio for BioStem Technologies, Inc. (BSEM) compare to its historical average?